Metoprolol "gea" (Metoprolol)

Metoprolol is a selective β1‑adrenergic blocker used in the management of cardiovascular disorders.

• Hypertension: reduces systemic blood pressure by decreasing cardiac output.
• Angina pectoris: lowers myocardial oxygen demand, relieving chest pain.
• Heart failure: improves survival and reduces hospitalizations by decreasing workload on the heart.
• Post‑myocardial infarction: lowers risk of recurrent events and arrhythmias.
• Cardiac arrhythmias: controls heart rate in certain supraventricular tachyarrhythmias.

• Metoprolol selectively antagonizes β1‑adrenergic receptors in cardiac tissue, inhibiting the effects of endogenous catecholamines. This leads to a reduction in heart rate, myocardial contractility, and conduction velocity, which together decrease cardiac output and lower arterial blood pressure, while also diminishing myocardial oxygen consumption.

Metoprolol may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Fatigue: feeling of tiredness or lack of energy.
• Dizziness: light‑headed sensation, especially when standing quickly.
• Bradycardia: slower than normal heart rate.
• Cold extremities: reduced blood flow to hands and feet.
• Gastrointestinal upset: nausea, abdominal discomfort.
• Depression: mood changes or low mood.

Serious or Rare Side Effects

• Severe bradycardia: markedly low heart rate requiring medical attention.
• Heart block: impaired electrical conduction in the heart.
• Hypotension: dangerously low blood pressure.
• Bronchospasm: narrowing of airways, especially in asthmatic patients.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Cardiogenic shock: acute failure of the heart to pump effectively.

Before initiating therapy, several safety considerations should be observed.

• Monitor blood pressure: ensure adequate control and avoid excessive lowering.
• Assess heart rate: watch for bradycardia, especially in patients with conduction disorders.
• Use caution in asthma or COPD: β1‑selectivity may still affect bronchial tone.
• Adjust dose in renal impairment: reduced clearance may increase exposure.
• Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia.
• Store at room temperature: keep in the original container, protect from moisture.

Metoprolol can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• Other beta blockers: additive cardiac depression.
• Calcium channel blockers (verapamil, diltiazem): may cause severe bradycardia or AV block.
• Antiarrhythmics (amiodarone, sotalol): increase risk of conduction abnormalities.
• Clonidine: abrupt withdrawal can precipitate hypertensive crisis.
• MAO inhibitors: may enhance hypotensive effects.

Moderate Interactions (Monitor Closely)

• NSAIDs: may reduce antihypertensive effect.
• Antidiabetic agents: may mask hypoglycemia symptoms.
• Antidepressants (SSRIs, SNRIs): potential for additive bradycardia.
• Diuretics: may increase risk of electrolyte imbalance.
• Digoxin: heightened risk of bradyarrhythmias.